ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 78 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q2 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $597,447 | -5.7% | 398,298 | 0.0% | 0.08% | -10.5% |
| Q2 2023 | $633,294 | +121.6% | 398,298 | 0.0% | 0.09% | +196.6% |
| Q1 2023 | $285,739 | +23.8% | 398,298 | 0.0% | 0.03% | +3.6% |
| Q4 2022 | $230,814 | -41.9% | 398,298 | -4.8% | 0.03% | -37.8% |
| Q3 2022 | $397,383 | -34.2% | 418,298 | -16.8% | 0.04% | -15.1% |
| Q2 2022 | $604,000 | -8.3% | 503,004 | 0.0% | 0.05% | +89.3% |
| Q1 2022 | $659,000 | -25.5% | 503,004 | 0.0% | 0.03% | -48.1% |
| Q4 2021 | $885,000 | +64.5% | 503,004 | +102.8% | 0.05% | +58.8% |
| Q3 2021 | $538,000 | -38.0% | 248,004 | 0.0% | 0.03% | -37.0% |
| Q2 2021 | $868,000 | – | 248,004 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 4,043,212 | $46,578,000 | 47.83% |
| Soleus Capital Management, L.P. | 342,800 | $3,949,000 | 3.81% |
| ACUTA CAPITAL PARTNERS, LLC | 1,322,500 | $15,235,000 | 3.77% |
| RTW INVESTMENTS, LP | 6,386,607 | $73,574,000 | 2.78% |
| Ghost Tree Capital, LLC | 1,175,000 | $13,536,000 | 2.58% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 480,000 | $5,530,000 | 2.48% |
| VHCP Management III, LLC | 946,234 | $10,901,000 | 2.16% |
| Avoro Capital Advisors LLC | 5,250,000 | $60,480,000 | 1.78% |
| VHCP Management II, LLC | 383,620 | $4,419,000 | 1.16% |
| Rhenman & Partners Asset Management AB | 650,000 | $7,488,000 | 0.82% |